We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Depomed Pulls Plug on Menopausal Hot Flash Drug After CR Letter
Depomed Pulls Plug on Menopausal Hot Flash Drug After CR Letter
June 19, 2013
Depomed has ended further investment in its menopausal hot flash drug, Sefelsa, after receiving a complete response letter that had been “expected” following an FDA advisory panel’s rejection of the drug.